Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

MMIT Reality Check on Immunology: Rheumatoid Arthritis (Mar 2017)

Posted by Matt Breese on Mar 27, 2017

According to our recent payer coverage analysis for rheumatoid arthritis treatments, combined with news from key healthcare influencers, market access is shifting in this immunology drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Market Access is Getting Harder

Posted by Matt Breese on Mar 24, 2017

Market access is getting harder.  We’ve seen this first hand with over 85 manufacturer clients and over 60 payer/PBM clients but anyone close to the industry feels the impact. Pharma pipelines expand with historical amounts of highly managed products in complex disease areas as brands launch into the market. 

Read More

Topics: Specialty, Market Access, Data & Analytics, Branding & Marketing

Trends That Matter for Pharma Data

Posted by Matt Breese on Mar 23, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is pharma data. Electronic Health Records (EHRs) help clinicians manage healthcare data.  In fact, 83% of physicians use EHRS, according to Medical Marketing and Media.

The Centers for Medicare and Medicaid Services describes the multitude of benefits EHRs provide:

"An Electronic Health Record (EHR) is an electronic version of a patients medical history, that is maintained by the provider over time, and may include all of the key administrative clinical data relevant to that persons care under a particular provider, including demographics, progress notes, problems, medications, vital signs, past medical history, immunizations, laboratory data and radiology reports." 

Read More

Topics: Industry Trends, Data & Analytics

MMIT Reality Check on Hereditary Angioedema (Mar 2017)

Posted by Matt Breese on Mar 22, 2017

According to our recent payer coverage analysis for hereditary angioedema treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Perspectives on Consumer Marketing

Posted by Matt Breese on Mar 21, 2017

Pharma manufacturers traditionally focus their marketing strategies on payers and prescribers, but the communication of treatment options directly to consumers has steadily gained importance as well as diversification. Pharma marketers now use promotional methods such as social media platforms, online communities, and community sponsorships to reach patients directly. When advertising directly to consumers, the communication goal is to deliver targeted and specific messages without excluding patient targets with a message that may be too narrow.

Read More

Topics: Industry Trends, Branding & Marketing

Trends That Matter for the Health Insurance Exchange

Posted by Matt Breese on Mar 16, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is health exchanges. The Health Insurance Marketplace allows individuals and families to compare options and purchase health insurance plans. 

According to the Department of Health and Humans Services, under the Affordable Care Act:

"The Health Insurance Marketplace gives eligible consumers options when purchasing a health plan, provides consumers with tools to compare options, and offers financial assistance in the form of advance premium tax credits that reduce the cost of health insurance to the majority of enrollees."

Read More

Topics: Industry Trends

Perspectives on the Value of Rebates

Posted by Matt Breese on Mar 14, 2017

Many pharma companies offer rebates to gain a competitive advantage. When offering rebates, manufacturers cover a portion of a drug's cost to make it less expensive for patients. Typically, these rebates apply to payer contracts that involve a relationship between a pharma company and a payer. Frequently, pharmacy benefit managers (PBMs) arrange rebates. PBMs can scale contracts better across their payer clients. 

Read More

Topics: Industry Trends, Market Access

MMIT Reality Check on Immune Globulin (Mar 2017)

Posted by Matt Breese on Mar 10, 2017

According to our recent payer coverage analysis for immune globulin treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Trends That Matter for Pharma Advertising

Posted by Matt Breese on Mar 9, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is pharma advertising. In today's digital landscape, pharma marketers are using online communication tools to target prescribers and physiciansThe emerging channels for healthcare advertising include mobile, video and social media.

Read More

Topics: Industry Trends, Branding & Marketing

Perspectives on Field Force Mapping

Posted by Matt Breese on Mar 7, 2017

Determining when and how to deploy a sales force is a critical component of a pharmaceutical marketing strategy. Whether a company is launching a new drug or simply refining their sales resources, multiple factors go into an effective field force strategy.  

Read More

Topics: Market Access, Branding & Marketing